과제정보
We thank the GEAR Core Lab core facility at the ConveRgence mEDIcine research cenTer (CREDIT), Asan Medical Center for the use of their shared equipment, services and expertise. This work was supported by the National Research Foundation of Korea (NRF) grants funded by the Korea government (MSIT) (NRF-2018R1A2B6007013, NRF-2021R1H1A2095350); and by a grant (2021IL0038) from the Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea.
참고문헌
- Altarejos, J.Y. and Montminy, M. (2011). CREB and the CRTC co-activators: sensors for hormonal and metabolic signals. Nat. Rev. Mol. Cell Biol. 12, 141-151. https://doi.org/10.1038/nrm3072
- Antonson, P., Schuster, G.U., Wang, L., Rozell, B., Holter, E., Flodby, P., Treuter, E., Holmgren, L., and Gustafsson, J.A. (2003). Inactivation of the nuclear receptor coactivator RAP250 in mice results in placental vascular dysfunction. Mol. Cell. Biol. 23, 1260-1268. https://doi.org/10.1128/MCB.23.4.1260-1268.2003
- Basu, R., Chandramouli, V., Dicke, B., Landau, B., and Rizza, R. (2005). Obesity and type 2 diabetes impair insulin-induced suppression of glycogenolysis as well as gluconeogenesis. Diabetes 54, 1942-1948. https://doi.org/10.2337/diabetes.54.7.1942
- Benchoula, K., Parhar, I.S., Madhavan, P., and Hwa, W.E. (2021). CREB nuclear transcription activity as a targeting factor in the treatment of diabetes and diabetes complications. Biochem. Pharmacol. 188, 114531. https://doi.org/10.1016/j.bcp.2021.114531
- Caira, F., Antonson, P., Pelto-Huikko, M., Treuter, E., and Gustafsson, J.A. (2000). Cloning and characterization of RAP250, a novel nuclear receptor coactivator. J. Biol. Chem. 275, 5308-5317. https://doi.org/10.1074/jbc.275.8.5308
- Chevalier, S., Burgess, S.C., Malloy, C.R., Gougeon, R., Marliss, E.B., and Morais, J.A. (2006). The greater contribution of gluconeogenesis to glucose production in obesity is related to increased whole-body protein catabolism. Diabetes 55, 675-681. https://doi.org/10.2337/diabetes.55.03.06.db05-1117
- Cline, G.W., Rothman, D.L., Magnusson, I., Katz, L.D., and Shulman, G.I. (1994). 13C-nuclear magnetic resonance spectroscopy studies of hepatic glucose metabolism in normal subjects and subjects with insulin-dependent diabetes mellitus. J. Clin. Invest. 94, 2369-2376. https://doi.org/10.1172/JCI117602
- Ekberg, K., Landau, B.R., Wajngot, A., Chandramouli, V., Efendic, S., Brunengraber, H., and Wahren, J. (1999). Contributions by kidney and liver to glucose production in the postabsorptive state and after 60 h of fasting. Diabetes 48, 292-298. https://doi.org/10.2337/diabetes.48.2.292
- Hanson, R.W. and Patel, Y.M. (1994). Phosphoenolpyruvate carboxykinase (GTP): the gene and the enzyme. Adv. Enzymol. Relat. Areas Mol. Biol. 69, 203-281.
- Jitrapakdee, S., Booker, G.W., Cassady, A.I., and Wallace, J.C. (1997). The rat pyruvate carboxylase gene structure. Alternate promoters generate multiple transcripts with the 5'-end heterogeneity. J. Biol. Chem. 272, 20522-20530. https://doi.org/10.1074/jbc.272.33.20522
- Jitrapakdee, S., Petchamphai, N., Sunyakumthorn, P., Wallace, J.C., and Boonsaeng, V. (2001). Structural and promoter regions of the murine pyruvate carboxylase gene. Biochem. Biophys. Res. Commun. 287, 411-417. https://doi.org/10.1006/bbrc.2001.5599
- Kim, G.H., Lee, K.J., Oh, G.S., Yoon, J., Kim, H.W., and Kim, S.W. (2012). Regulation of hepatic insulin sensitivity by activating signal cointegrator-2. Biochem. J. 447, 437-447. https://doi.org/10.1042/BJ20120861
- Kim, G.H., Oh, G.S., Yoon, J., Lee, G.G., Lee, K.U., and Kim, S.W. (2015). Hepatic TRAP80 selectively regulates lipogenic activity of liver X receptor. J. Clin. Invest. 125, 183-193. https://doi.org/10.1172/JCI73615
- Ko, L., Cardona, G.R., and Chin, W.W. (2000). Thyroid hormone receptor-binding protein, an LXXLL motif-containing protein, functions as a general coactivator. Proc. Natl. Acad. Sci. U. S. A. 97, 6212-6217. https://doi.org/10.1073/pnas.97.11.6212
- Lee, S.K., Anzick, S.L., Choi, J.E., Bubendorf, L., Guan, X.Y., Jung, Y.K., Kallioniemi, O.P., Kononen, J., Trent, J.M., Azorsa, D., et al. (1999). A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivator essential for ligand-dependent transactivation by nuclear receptors in vivo. J. Biol. Chem. 274, 34283-34293. https://doi.org/10.1074/jbc.274.48.34283
- Magnusson, I., Rothman, D.L., Katz, L.D., Shulman, R.G., and Shulman, G.I. (1992). Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. J. Clin. Invest. 90, 1323-1327. https://doi.org/10.1172/JCI115997
- Mahajan, M.A., Das, S., Zhu, H., Tomic-Canic, M., and Samuels, H.H. (2004). The nuclear hormone receptor coactivator NRC is a pleiotropic modulator affecting growth, development, apoptosis, reproduction, and wound repair. Mol. Cell. Biol. 24, 4994-5004. https://doi.org/10.1128/MCB.24.11.4994-5004.2004
- Mahajan, M.A. and Samuels, H.H. (2000). A new family of nuclear receptor coregulators that integrate nuclear receptor signaling through CREB-binding protein. Mol. Cell. Biol. 20, 5048-5063. https://doi.org/10.1128/MCB.20.14.5048-5063.2000
- Modaressi, S., Brechtel, K., Christ, B., and Jungermann, K. (1998). Human mitochondrial phosphoenolpyruvate carboxykinase 2 gene. Structure, chromosomal localization and tissue-specific expression. Biochem. J. 333 (Pt 2), 359-366.
- Nordlie, R.C. and Lardy, H.A. (1963). Mammalian liver phosphoneolpyruvate carboxykinase activities. J. Biol. Chem. 238, 2259-2263. https://doi.org/10.1016/S0021-9258(19)67962-7
- Oh, G.S., Lee, G.G., Yoon, J., Oh, W.K., and Kim, S.W. (2015). Selective inhibition of liver X receptor α-mediated lipogenesis in primary hepatocytes by licochalcone A. Chin. Med. 10, 8. https://doi.org/10.3760/cma.j.issn.1673-4777.2015.01.003
- Paz, J.C., Park, S., Phillips, N., Matsumura, S., Tsai, W.W., Kasper, L., Brindle, P.K., Zhang, G., Zhou, M.M., Wright, P.E., et al. (2014). Combinatorial regulation of a signal-dependent activator by phosphorylation and acetylation. Proc. Natl. Acad. Sci. U. S. A. 111, 17116-17121. https://doi.org/10.1073/pnas.1420389111
- Petersen, M.C., Vatner, D.F., and Shulman, G.I. (2017). Regulation of hepatic glucose metabolism in health and disease. Nat. Rev. Endocrinol. 13, 572-587. https://doi.org/10.1038/nrendo.2017.80
- Rui, L. (2014). Energy metabolism in the liver. Compr. Physiol. 4, 177-197. https://doi.org/10.1002/cphy.c130024
- Samuel, V.T., Liu, Z.X., Qu, X., Elder, B.D., Bilz, S., Befroy, D., Romanelli, A.J., and Shulman, G.I. (2004). Mechanism of hepatic insulin resistance in nonalcoholic fatty liver disease. J. Biol. Chem. 279, 32345-32353. https://doi.org/10.1074/jbc.M313478200
- Thiel, G., Al Sarraj, J., and Stefano, L. (2005). cAMP response element binding protein (CREB) activates transcription via two distinct genetic elements of the human glucose-6-phosphatase gene. BMC Mol. Biol. 6, 2. https://doi.org/10.1186/1471-2199-6-2
- Thonpho, A., Sereeruk, C., Rojvirat, P., and Jitrapakdee, S. (2010). Identification of the cyclic AMP responsive element (CRE) that mediates transcriptional regulation of the pyruvate carboxylase gene in HepG2 cells. Biochem. Biophys. Res. Commun. 393, 714-719. https://doi.org/10.1016/j.bbrc.2010.02.067
- Wajngot, A., Chandramouli, V., Schumann, W.C., Ekberg, K., Jones, P.K., Efendic, S., and Landau, B.R. (2001). Quantitative contributions of gluconeogenesis to glucose production during fasting in type 2 diabetes mellitus. Metabolism 50, 47-52. https://doi.org/10.1053/meta.2001.19422
- Wolfe, K.B. and Long, D.T. (2019). Chromatin immunoprecipitation (ChIP) of plasmid-bound proteins in Xenopus egg extracts. Methods Mol. Biol. 1999, 173-184. https://doi.org/10.1007/978-1-4939-9500-4_10
- Xing, L. and Quinn, P.G. (1993). Involvement of 3',5'-cyclic adenosine monophosphate regulatory element binding protein (CREB) in both basal and hormone-mediated expression of the phosphoenolpyruvate carboxykinase (PEPCK) gene. Mol. Endocrinol. 7, 1484-1494. https://doi.org/10.1210/mend.7.11.8114762
- Yeom, S.Y., Kim, G.H., Kim, C.H., Jung, H.D., Kim, S.Y., Park, J.Y., Pak, Y.K., Rhee, D.K., Kuang, S.Q., Xu, J., et al. (2006). Regulation of insulin secretion and β-cell mass by activating signal cointegrator 2. Mol. Cell. Biol. 26, 4553-4563. https://doi.org/10.1128/MCB.01412-05
- Zhang, K., Yin, R., and Yang, X. (2014). O-GlcNAc: a bittersweet switch in liver. Front. Endocrinol. 5, 221. https://doi.org/10.3389/fendo.2014.00221
- Zhu, Y., Kan, L., Qi, C., Kanwar, Y.S., Yeldandi, A.V., Rao, M.S., and Reddy, J.K. (2000). Isolation and characterization of peroxisome proliferator-activated receptor (PPAR) interacting protein (PRIP) as a coactivator for PPAR. J. Biol. Chem. 275, 13510-13516. https://doi.org/10.1074/jbc.275.18.13510
- Zhu, Y.J., Crawford, S.E., Stellmach, V., Dwivedi, R.S., Rao, M.S., Gonzalez, F.J., Qi, C., and Reddy, J.K. (2003). Coactivator PRIP, the peroxisome proliferator-activated receptor-interacting protein, is a modulator of placental, cardiac, hepatic, and embryonic development. J. Biol. Chem. 278, 1986-1990. https://doi.org/10.1074/jbc.C200634200